Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for neuropathic pain after complex lower limb trauma
ACTRN12611000118909Phase 2Withdrawn
- Sponsor
- Dr David Lindholm
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neuralgia comparing Minocycline with Placebo (2 arms). Primary endpoints: Numerical Rating Scale of pain at 6 months and Leeds Assessment of Neuropathic Symptoms and Signs at 6 months. Planned start Oct 2013; status: withdrawn.
02
Drugs
minocycline
03
Conditions
Neuralgia
Beyond the preview
Go deeper on ACTRN12611000118909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000118909.